December 28, 2020: "AstraZeneca and MSD’s Lynparza (olaparib) has been approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers.
The three approvals authorise Lynparza for:...
December 24, 2020: "President Trump is taking another step to protect the health of the American people by requiring air passengers arriving from the...
December 23, 2020: The U.S. FDA authorized marketing of the EndoRotor System to resect (cut out) and remove necrotic (dead) tissue for patients with...
December 22, 2020: "Ocugen, Inc., a leading biopharmaceutical company, and Bharat Biotech, a global leader in vaccine innovation announced that the companies have signed...
December 23, 2020: "Pfizer Inc. and BioNTech SE announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’...
December 22, 2020: Ridgeback Biotherapeutics LP, a biotechnology company experienced in antiviral drug development, announced today that the U.S.FDA approved EbangaTMÂ for the treatment of...
December 22, 2020: "The U.S. FDA issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal...
Marketing Authorisation granted by European Commission for ViiV Healthcare’s Vocabria (cabotegravir injection and tablets) to be used with Janssen’s Rekambys (rilpivirine injection) and Edurant...
 December 21, 2020: "Pfizer and BioNTech announced that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY® (also...